StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Evercore ISI Reiterates Outperform Rating on Abbott Labs (ABT), PT $120
July 18, 2024 8:59 AM
Evercore ISI analyst Vijay Kumar reiterated an Outperform rating and $120.00 price target on Abbott Labs (NYSE: ABT).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
UBS Reiterates Buy Rating on Abbott Labs (ABT)
July 19, 2024 6:17 AM
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT), PT $130
July 18, 2024 8:53 AM
Stifel Reiterates Buy Rating on Abbott Labs (ABT)
July 18, 2024 8:50 AM
Citi Reiterates Buy Rating on Abbott Labs (ABT)
July 18, 2024 8:49 AM
Form 8-K ABBOTT LABORATORIES For: Jul 18
July 18, 2024 7:38 AM
Abbott raises profit forecast on strong medical device sales
July 18, 2024 7:32 AM
Abbott (ABT) Tops Q2 EPS by 3c, Updates Guidance
July 18, 2024 7:32 AM
Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance
July 18, 2024 7:30 AM
Abbott (ABT) call put ratio 4.9 calls to 1 put into quarter results
July 17, 2024 11:28 AM
Abbott (ABT) July 103 straddle into quarter results
July 17, 2024 6:18 AM
